"Designing Growth Strategies is in our DNA"
The global ATP monitoring consumables market size was valued at USD 66.0 million in 2024. The market is projected to grow from USD 68.9 million in 2025 to USD 97.7 million by 2032, exhibiting a CAGR of 5.1% during the forecast period. North America dominated the ATP monitoring consumables market with a market share of 45.54% in 2024.
ATP (adenosine triphosphate) monitoring devices are used to measure levels of ATP on a surface, and thus the cleanliness levels of a facility. The ATP system uses a hand-held device called a luminometer, which is combined with a sampling swab to identify the cleanliness of any surface in healthcare facilities.
The growth of the global ATP monitoring consumables market is driven by an increasing number of hospital-acquired infection cases and the increasing utilization of ATP detection products in healthcare facilities.
Furthermore, the market comprises several small and mid-size companies such as Solventum, Hygiena LLC, Getinge, and Neogen Corporation. These key players are actively participating in medical conferences to create product awareness among consumers.
High Incidence of Hospital-acquired Infections is Driving Market Growth
The rising cases of hospital-acquired infections (HAIs) are increasing the demand for ATP monitoring consumables in healthcare facilities. Common hospital-acquired infections (HAIs), including sepsis, catheter-associated urinary tract infections (CAUTI), ventilator-associated pneumonia, and surgical site infections, are increasing substantially across the world, placing immense pressure on hospitals and specialty clinics to strengthen their hygiene protocols.
The ATP monitoring products provide an effective method for assessing cleanliness by detecting harmful pathogens, such as Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis. This increases demand for ATP monitoring products and related consumables such as swabs and reagents, particularly for validating the cleanliness of surgical equipment and rooms.
Growing Emphasis from Regulatory Authorities to Mandate Sterilization in Healthcare Facilities to Augment Market Growth
The increasing emphasis by regulatory authorities on mandating sterilization protocols in healthcare settings is one of the important factors driving market growth. Government regulations such as the U.S. Food and Drug Administration (FDA), International Organisation for Standardisation (ISO), and others have made hygiene verification mandatory across several healthcare sectors, thereby reinforcing the need for ATP consumables.
As infection control becomes a top priority, particularly in the case of hospital-acquired infections, the government authorities of respective countries are implementing standard sterilization protocols to ensure patients' safety.
Over the past few years, ATP monitoring products have been recognized as a reliable and effective tool for assessing cleanliness and contamination in surgical rooms, ICUs, and equipment sterilization areas. Healthcare settings are adopting consumables such as swabs, reagents, and others to meet the regulatory requirements. These factors are collectively driving the ATP monitoring consumables market growth.
Lack of Skilled Professionals in Developing Countries Restricts Market Growth
The developing nations, which lack trained and skilled professionals capable of effectively using and interpreting ATP monitoring systems, are hindering market growth. Although designed for rapid hygiene monitoring, these systems require a basic knowledge of equipment calibration, microbiology, swabbing technique, and data interpretation to ensure accurate results.
Several developing countries, especially the resource-constrained settings, have a shortage of trained microbiologists and quality assurance personnel. In addition, when facilities invest in ATP monitoring devices, they face challenges in maintaining and operating them due to a lack of skilled personnel.
Limited Awareness about Effective Sterilization in Emerging Nations Hinders Market Growth
The limited awareness and ignorance of sterilization standards among healthcare facilities in low-income countries further hampers the demand for ATP monitoring products, which are used to verify the effectiveness of cleaning processes before sterilization. For instance, as per the data published by the National Centers for Biotechnology Information (NCBI) in November 2023, in India, out of every 100 patients admitted to the hospitals, at least 15 have a chance to develop hospital-acquired infection (HAI).
Expansion of Pharmaceutical and Medical Devices Manufacturing in Developing Nations Creating Opportunities for Market Growth
The rapid growth of pharmaceutical, biopharmaceutical, and medical device manufacturing in developing nations such as India, China, and Brazil creates a significant opportunity for market growth. As these sectors expand, they must follow stringent regulatory standards for cleanliness and contamination control, in line with international guidelines such as Good Manufacturing Practices (GMP). Additionally, the increasing focus of pharmaceutical and medical device companies on expanding their manufacturing capacity is expected to create growth opportunities for market players.
The ATP monitoring offers a fast and reliable method for verifying cleanliness in the manufacturing areas. With rising manufacturing activities, the need for frequent hygiene verification also increases, resulting in the increased usage of ATP monitoring solutions.
High Cost of ATP Monitoring Consumables to Limit Their Adoption in Low-income Countries
The high cost of ATP monitoring products represents a substantial barrier to widespread adoption in low-income nations. The ATP monitoring devices require frequent purchasing of consumables, such as swabs, reagents, and others. Moreover, many of these products are priced to align with the standards of nations with advanced healthcare infrastructure, making them inaccessible for healthcare settings in low-income countries. Furthermore, the low-income countries have limited budgets for healthcare spending, limiting the adoption of ATP monitoring products and related consumables.
Thus, the high cost of consumables limits the scalability of ATP monitoring products in low-income countries. This poses a significant market challenge for manufacturers aiming to expand their footprints globally.
Availability of Other Sterilization Validation Products to Pose Significant Market Challenge
The availability of other sterilization validation products, such as biological indicators, chemical indicators, and indicator tapes, may limit the adoption of ATP monitoring consumables, thereby hindering market growth.
Biological indicators are considered the gold standard for sterilization validation as they directly test the sterilization process's effectiveness using highly resistant microbial spores. Also, the biological indicators confirm the killing of microorganisms, which ATP monitoring consumables cannot. Market players are increasingly focusing on the launch of biological indicators to validate the sterilization process. For example, in December 2020, STERIS announced the global launch of Spordex self-contained biological indicator (SCBI) ampoules to confirm sterilization of liquids in steam autoclave cycles.
Furthermore, the chemical indicators are cheaper than ATP monitoring consumables, increasing their adoption in low-income countries.
Download Free sample to learn more about this report.
Integration of ATP Monitoring Products with Digital Platforms to Spur Market Development
Integrating ATP monitoring systems with digital platforms is a key market trend that significantly transforms hygiene and contamination control methods. This trend enhances the efficiency and accuracy of monitoring processes and increases the usage of ATP consumables. As a result, various healthcare sectors are adopting ATP monitoring products, contributing to overall market growth.
Increasing Launch of Swabs to Perform ATP Monitoring Boosted Segment Growth
Based on product, the market is divided into swabs, reagents, and others.
The swabs segment dominated the global market in 2024 and is expected to grow at the highest CAGR during the forecast period. One of the key factors driving this growth is the increasing market players' focus on the launch of ATP monitoring swabs to ensure the cleanliness of the surfaces in the healthcare setting. For example, in May 2024, GuangDong Dayuan & Oasis FoodTech Ltd. announced the launch of the Surface ATP test swab in the global market.
The reagents segment accounted for a moderate market share in 2024 and is anticipated to grow at a moderate CAGR during the forecast period, owing to increasing utilization of ATP monitoring reagents by pharma and medical device industries in the sterilization process.
Steam Sterilization Segment Dominated Due to Its High Adoption at Healthcare Facilities
In terms of sterilization method, the market is segmented into steam sterilization, hydrogen peroxide sterilization, ethylene oxide sterilization, and others.
The steam sterilization segment held a dominant global ATP monitoring consumables market share in 2024 and is estimated to grow at the second-largest CAGR from 2025-2032. The segment's growth is attributed to the rising adoption of steam sterilizers at healthcare facilities.
The hydrogen peroxide sterilization segment accounted for the second-largest market share in 2024 and is estimated to grow at the highest CAGR from 2025-2032. The rising adoption of the hydrogen peroxide sterilization method by manufacturers and service providers for effective sterilization of pharmaceuticals and medical devices is one of the major factors augmenting the segment’s growth.
The others segment is anticipated to grow at a stagnant CAGR during the forecast period. Opening new sterilization facilities and expanding existing sterilization services facilities, including ionizing sterilization, are important factors driving the segment’s growth.
Hospital & Clinics Segment Dominated Market Due to the Opening of New Advanced Sterilization Facilities
In terms of end user, the market is segmented into hospitals & clinics, pharmaceutical & medical device manufacturers, and others.
The hospitals & clinics segment dominated the global market in 2024 and is expected to grow at the highest CAGR from 2025 to 2032, owing to the opening of new sterilization facilities providing sterilization services to hospitals and clinics globally. For instance, in March 2023, Servizi Italia Spa announced the inauguration of its first sterilization plant in São Paulo, Brazil. This facility provides steam sterilization services to the São Paulo, Brazil, hospitals.
The pharmaceutical & medical device manufacturers segment is expected to grow moderately during the forecast period. The growing demand for ATP monitoring products by the pharmaceutical and medical device industries for pharmaceutical and medical device manufacturing is driving the segment’s growth. Additionally, opening new pharmaceutical and medical device manufacturing facilities further supplements segment growth.
The others segment is expected to grow at a stagnant CAGR throughout the forecast period, owing to increasing usage of ATP monitoring consumables by academic and research institutes to assess the cleanliness of surfaces while performing research activities.
In terms of region, the global market can be divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America ATP Monitoring Consumables Market Size, 2024 (USD Million)
To get more information on the regional analysis of this market, Download Free sample
North America accounted for a market size of USD 30.6 million in 2024 and dominated the market with a share of 46.3%. The region’s market growth is attributed to the presence of advanced healthcare infrastructure and a large number of market players providing ATP monitoring products and related consumables.
Furthermore, the high burden of hospital-acquired infections in the U.S. has led to an increase in demand for ATP monitoring products in healthcare facilities, fueling market growth in the U.S.
Europe accounted for the second-largest share of the market in 2024 and is anticipated to grow at the second-largest CAGR during the forecast period. The increasing market players' focus on participating in medical conferences to create awareness about medical products and related consumables among healthcare professionals is one of the important factors driving market growth across Europe.
Asia Pacific held a moderate market share in 2024 and is anticipated to grow at the highest CAGR throughout the forecast period. The increasing market players' focus on expanding their footprints in this region by opening new facilities is one of the main factors driving market growth in this region.
The ATP monitoring consumables market in Latin America and the Middle East & Africa is expected to grow at a considerable CAGR throughout the forecast period. The increasing market players' focus on creating awareness about sterilization solutions, including ATP monitoring products among healthcare professionals, is enhancing market growth in these regions.
Market Players Focus on Participating in Medical Conferences to Create Product Awareness among Consumers
The market is fragmented with the presence of several small and mid-sized companies. The market comprises major players, such as Solventum, Hygiena LLC, Getinge, and Terragene. These companies hold a substantial proportion of the market due to their strong focus on attending medical conferences to create brand awareness among consumers.
Moreover, other players in the market include Neogen Corporation, NEMIS Technologies AG, Ruhof, and Meizheng. These companies have been focusing on new product launches to enhance their portfolio and expand their footprint in the global market.
The global ATP monitoring consumables market report provides a detailed competitive landscape and market insights. In addition to the market size, it covers regional analysis of different market segments, profiles of key market players, and market dynamics. Moreover, the market report encompasses several factors contributing to the market's growth over recent years.
To gain extensive insights into the market, Download for Customization
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2019-2032 |
|
Base Year |
2024 |
|
Estimated Year |
2025 |
|
Forecast Period |
2025-2032 |
|
Historical Period |
2019-2023 |
|
Growth Rate |
CAGR of 5.1% from 2025-2032 |
|
Unit |
Value (USD million) |
|
Segmentation |
By Sterilization Method
|
|
By End-user
|
|
|
By Region
|
Fortune Business Insights says that the global market stood at USD 66.0 million in 2024 and is projected to reach USD 97.7 million by 2032.
In 2024, the market value in North America stood at USD 30.6 million.
The market will exhibit steady growth at a CAGR of 5.1% during the forecast period (2025-2032).
By product, the swabs segment led the market.
The increasing prevalence of hospital-acquired infections and regulatory authorities' growing emphasis on mandating sterilization in healthcare facilities are important factors driving market growth.
Solventum, Hygiena LLC, Neogen Corporation, and Getinge are the top players operating in the market.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )